YolTech raises $70.0M (China, May 2026)
$70.0M
$70MGenerated social card
Headline
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward - Endpoints News
About
YolTech is a gene editing startup focused on advancing CRISPR therapies. The company aims to develop innovative treatments in the field of genetic medicine and is preparing for a public offering in Hong Kong.
Article summary
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward Endpoints News
Founder
Yuxuan Wu
CEO
Investors
Related rounds
| May 27, 2026 | Shanghai Volant Aerotech Co., Ltd. | $147.0M | Series C+ | China |
| May 27, 2026 | Waypoint Bio | $20.0M | — | China |
| May 25, 2026 | Meng Xiaoyi | $1.0M | Seed | China |
| May 24, 2026 | Manus | $1.00B | — | China |